DENVER--(BUSINESS WIRE)--Jan. 3, 2006--Corgenix Medical Corporation (OTC Bulletin Board: CONX; “Corgenix” or the “Company”), a worldwide developer and marketer of diagnostic test kits, announced the closing of two private placement financing agreements with selected institutional and accredited investors representing initial gross proceeds to the Company of up to $3,363,500.